Skip to main content

  • Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention

    • Posted: 02/23/2023
    • Author:

      Brian C. Case, Rebecca Torguson, Jonathan Abramowitz, Corey Shea, Cheng Zhang, Joseph A. Sutton, Teshome Deksissa, Lowell F. Satler, Itsik Ben-Dor, Nelson L. Bernardo, Hayder Hashim, Toby Rogers and Ron Waksman

    • CRM2023News

    Abstract

    Background

    Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the mainstay regimen for acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). We aimed to investigate DAPT compliance and switching patterns in ACS patients prescribed ticagrelor and aspirin. Secondly, we evaluated the impact of a pilot strategy of close surveillance telephone calls.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details